Faculty of Kinesiology & Physical Education, University of Toronto, Toronto, ON, Canada; Defence Research and Development Canada, Toronto Research Centre, Toronto, ON, Canada.
Neuroscience Program, Keenan Research Centre for Biomedical Science of St. Michael's Hospital, Toronto, ON, Canada.
J Neuroimmunol. 2018 Jun 15;319:1-8. doi: 10.1016/j.jneuroim.2018.03.002. Epub 2018 Mar 18.
Secondary injury pathophysiology after sport-related concussion (SRC) is poorly understood. Blood biomarkers may be a useful tool for characterizing these processes, yet there are limitations in their application as a single modality. Combining blood biomarker analysis with advanced neuroimaging may help validate their continued utility in brain injury research by elucidating important secondary injury mechanisms. Hence, the purpose of this study was to evaluate co-modulation between peripheral blood biomarkers and advanced functional brain imaging after SRC.
Forty-three university level athletes from 7 sports were recruited (16 recently concussed athletes; 15 healthy athletes with no prior history of concussion; 12 healthy athletes with a history of concussion). Seven blood biomarkers were evaluated: s100B, total tau (T-tau), von Willebrand factor (vWF), brain derived neurotrophic factor (BDNF), peroxiredoxin (PRDX)-6, monocyte chemoattractant protein (MCP)-1 and -4. Resting-state functional MRI was employed to assess global neural connectivity (Gconn), and arterial spin labelling was used to evaluate cerebral blood flow (CBF). We tested for concurrent alterations in blood biomarkers and MRI measures of brain function between athlete groups using a non-parametric, bootstrapped resampling framework.
Compared to healthy athletes, recently concussed athletes showed greater concurrent alterations in several peripheral blood biomarker and MRI measures: a decrease in T-Tau and Gconn, a decrease in T-Tau and CBF, a decrease in Gconn with elevated PRDX-6, a decrease in CBF with elevated PRDX-6, and a decrease in Gconn with elevated MCP-4. In addition, compared to healthy athletes with no concussion history, healthy athletes with a history of concussion displayed greater concurrent alterations in blood biomarkers and Gconn; lower GConn covaried with higher blood levels of s100B and MCP-4.
We identified robust relationships between peripheral blood biomarkers and MRI measures in both recently concussed athletes and healthy athletes with a history of concussion. The results from this combinatorial approach further support that human concussion is associated with inflammation, oxidative stress, and cellular damage, and that physiological perturbations may extend chronically beyond recovery. Finally, our results support the continued implementation of blood biomarkers as a tool to investigate brain injury, particularly in a multimodal framework.
运动相关脑震荡(SRC)后的继发性损伤病理生理学尚不清楚。血液生物标志物可能是描述这些过程的有用工具,但作为单一模式存在应用限制。将血液生物标志物分析与先进的神经影像学相结合,通过阐明重要的继发性损伤机制,可能有助于验证其在脑损伤研究中的持续效用。因此,本研究旨在评估 SRC 后外周血生物标志物与先进的功能脑成像之间的共同调节。
招募了来自 7 种运动的 43 名大学生运动员(16 名近期脑震荡运动员;15 名无既往脑震荡史的健康运动员;12 名有脑震荡史的健康运动员)。评估了 7 种血液生物标志物:S100B、总 tau(T-tau)、血管性血友病因子(vWF)、脑源性神经营养因子(BDNF)、过氧化物还原酶 6(PRDX-6)、单核细胞趋化蛋白 1(MCP-1)和 -4。使用静息状态功能磁共振成像评估全局神经连接(Gconn),并使用动脉自旋标记评估脑血流(CBF)。我们使用非参数、引导重采样框架测试运动员组之间血液生物标志物和脑功能 MRI 测量的同时变化。
与健康运动员相比,近期脑震荡运动员的几种外周血生物标志物和 MRI 测量值同时发生了更大的变化:T-Tau 和 Gconn 降低,T-Tau 和 CBF 降低,PRDX-6 升高时 Gconn 降低,PRDX-6 升高时 CBF 降低,Gconn 升高时 MCP-4 降低。此外,与无既往脑震荡史的健康运动员相比,有脑震荡史的健康运动员的血液生物标志物和 Gconn 同时发生了更大的变化;较低的 GConn 与较高的血液 s100B 和 MCP-4 水平相关。
我们在近期脑震荡运动员和有脑震荡史的健康运动员中发现了外周血生物标志物与 MRI 测量值之间的强大关系。这种组合方法的结果进一步支持人类脑震荡与炎症、氧化应激和细胞损伤有关,并且生理扰动可能会在恢复后长期持续存在。最后,我们的结果支持将血液生物标志物作为一种研究脑损伤的工具继续实施,特别是在多模态框架中。